Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 136

1.

Comparative effectiveness of next generation genomic sequencing for disease diagnosis: Design of a randomized controlled trial in patients with colorectal cancer/polyposis syndromes.

Gallego CJ, Bennette CS, Heagerty P, Comstock B, Horike-Pyne M, Hisama F, Amendola LM, Bennett RL, Dorschner MO, Tarczy-Hornoch P, Grady WM, Fullerton SM, Trinidad SB, Regier DA, Nickerson DA, Burke W, Patrick DL, Jarvik GP, Veenstra DL.

Contemp Clin Trials. 2014 Jul 3;39(1):1-8. doi: 10.1016/j.cct.2014.06.016. [Epub ahead of print]

PMID:
24997220
[PubMed - as supplied by publisher]
2.

Long-term survival in patients with severe acute respiratory distress syndrome and rescue therapies for refractory hypoxemia*.

Khandelwal N, Hough CL, Bansal A, Veenstra DL, Treggiari MM.

Crit Care Med. 2014 Jul;42(7):1610-8. doi: 10.1097/CCM.0000000000000322.

PMID:
24732240
[PubMed - in process]
3.

Targeted erlotinib for first-line treatment of advanced non-small cell lung cancer: a budget impact analysis.

Bajaj PS, Veenstra DL, Goertz HP, Carlson JJ.

J Med Econ. 2014 Aug;17(8):538-46. doi: 10.3111/13696998.2014.912987. Epub 2014 May 12.

PMID:
24716717
[PubMed - in process]
4.

Genetic risk factors for major bleeding in patients treated with warfarin in a community setting.

Roth JA, Boudreau D, Fujii MM, Farin FM, Rettie AE, Thummel KE, Veenstra DL.

Clin Pharmacol Ther. 2014 Jun;95(6):636-43. doi: 10.1038/clpt.2014.26. Epub 2014 Feb 6.

PMID:
24503627
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Is a comparative clinical trial for breast cancer tumor markers to monitor disease recurrence warranted? A value of information analysis.

Thariani R, Henry NL, Ramsey SD, Blough DK, Barlow B, Gralow JR, Veenstra DL.

J Comp Eff Res. 2013 May;2(3):325-34. doi: 10.2217/cer.13.15.

PMID:
24236631
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

The EGAPP initiative: lessons learned.

Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group.

Genet Med. 2014 Mar;16(3):217-24. doi: 10.1038/gim.2013.110. Epub 2013 Aug 8.

PMID:
23928914
[PubMed - in process]
7.

Recommendations for prophylaxis of pregnancy-related venous thromboembolism in carriers of inherited thrombophilia. Comment on the 2012 ACCP guidelines: a rebuttal.

Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos AM, Vandvik PO.

J Thromb Haemost. 2013 Sep;11(9):1782-4. doi: 10.1111/jth.12347. No abstract available.

PMID:
23819793
[PubMed - indexed for MEDLINE]
8.

Cost-effectiveness of pharmacogenetic-guided dosing of phenprocoumon in atrial fibrillation.

Verhoef TI, Redekop WK, Veenstra DL, Thariani R, Beltman PA, van Schie RM, de Boer A, Maitland-van der Zee AH; EU-PACT Group.

Pharmacogenomics. 2013 Jun;14(8):869-83. doi: 10.2217/pgs.13.74.

PMID:
23746182
[PubMed - indexed for MEDLINE]
9.

Return of incidental findings in genomic medicine: measuring what patients value--development of an instrument to measure preferences for information from next-generation testing (IMPRINT).

Bennette CS, Trinidad SB, Fullerton SM, Patrick D, Amendola L, Burke W, Hisama FM, Jarvik GP, Regier DA, Veenstra DL.

Genet Med. 2013 Nov;15(11):873-81. doi: 10.1038/gim.2013.63. Epub 2013 May 30.

PMID:
23722871
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Value-of-information analysis within a stakeholder-driven research prioritization process in a US setting: an application in cancer genomics.

Carlson JJ, Thariani R, Roth J, Gralow J, Henry NL, Esmail L, Deverka P, Ramsey SD, Baker L, Veenstra DL.

Med Decis Making. 2013 May;33(4):463-71. doi: 10.1177/0272989X13484388.

PMID:
23635833
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

The economics of genomic medicine: insights from the IOM Roundtable on Translating Genomic-Based Research for Health.

Feero WG, Wicklund C, Veenstra DL.

JAMA. 2013 Mar 27;309(12):1235-6. doi: 10.1001/jama.2013.113. No abstract available.

PMID:
23532238
[PubMed - indexed for MEDLINE]
12.

The validity of dependence as a health outcome measure in Alzheimer's disease.

Spackman DE, Kadiyala S, Neumann PJ, Veenstra DL, Sullivan SD.

Am J Alzheimers Dis Other Demen. 2013 May;28(3):245-52. doi: 10.1177/1533317513481092. Epub 2013 Mar 19.

PMID:
23512996
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Facilitating comparative effectiveness research in cancer genomics: evaluating stakeholder perceptions of the engagement process.

Deverka PA, Lavallee DC, Desai PJ, Armstrong J, Gorman M, Hole-Curry L, O'Leary J, Ruffner BW, Watkins J, Veenstra DL, Baker LH, Unger JM, Ramsey SD.

J Comp Eff Res. 2012 Jul;1(4):359-70.

PMID:
23459832
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Recommendations from the EGAPP Working Group: can testing of tumor tissue for mutations in EGFR pathway downstream effector genes in patients with metastatic colorectal cancer improve health outcomes by guiding decisions regarding anti-EGFR therapy?

Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group.

Genet Med. 2013 Jul;15(7):517-27. doi: 10.1038/gim.2012.184. Epub 2013 Feb 21.

PMID:
23429431
[PubMed - indexed for MEDLINE]
15.

Navigational bronchoscopy with biopsy versus computed tomography-guided biopsy for the diagnosis of a solitary pulmonary nodule: a cost-consequences analysis.

Dale CR, Madtes DK, Fan VS, Gorden JA, Veenstra DL.

J Bronchology Interv Pulmonol. 2012 Oct;19(4):294-303. doi: 10.1097/LBR.0b013e318272157d. Review.

PMID:
23207529
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

A risk-benefit analysis of factor V Leiden testing to improve pregnancy outcomes: a case study of the capabilities of decision modeling in genomics.

Bajaj PS, Veenstra DL.

Genet Med. 2013 May;15(5):374-81. doi: 10.1038/gim.2012.139. Epub 2012 Nov 8.

PMID:
23138100
[PubMed - indexed for MEDLINE]
17.

Getting our priorities straight: a novel framework for stakeholder-informed prioritization of cancer genomics research.

Esmail LC, Roth J, Rangarao S, Carlson JJ, Thariani R, Ramsey SD, Veenstra DL, Deverka P.

Genet Med. 2013 Feb;15(2):115-22. doi: 10.1038/gim.2012.103. Epub 2012 Oct 4.

PMID:
23037935
[PubMed - indexed for MEDLINE]
18.

The value of comparative effectiveness research: projected return on investment of the RxPONDER trial (SWOG S1007).

Wong WB, Ramsey SD, Barlow WE, Garrison LP Jr, Veenstra DL.

Contemp Clin Trials. 2012 Nov;33(6):1117-23. doi: 10.1016/j.cct.2012.08.006. Epub 2012 Aug 18.

PMID:
22981891
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Improving the efficiency and relevance of evidence-based recommendations in the era of whole-genome sequencing: an EGAPP methods update.

Veenstra DL, Piper M, Haddow JE, Pauker SG, Klein R, Richards CS, Tunis SR, Djulbegovic B, Marrone M, Lin JS, Berg AO, Calonge N.

Genet Med. 2013 Jan;15(1):14-24. doi: 10.1038/gim.2012.106. Epub 2012 Sep 6. Review.

PMID:
22955111
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Stakeholder perspectives on decision-analytic modeling frameworks to assess genetic services policy.

Guzauskas GF, Garrison LP, Stock J, Au S, Doyle DL, Veenstra DL.

Genet Med. 2013 Jan;15(1):84-7. doi: 10.1038/gim.2012.92. Epub 2012 Jul 26.

PMID:
22836698
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk